A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma

Clinical trial NCT03530683 · TERMINATED

Trial details

NCT number: NCT03530683
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma Multiple Myeloma Acute Myeloid Leukemia Diffuse Large B-Cell Lymphoma

Start date: 2018-05-14
Primary completion: 2024-07-18
Enrollment: 189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.